Agency Information Collection Activities: Proposed Collection; Comment Request, 7124-7126 [2016-02686]
Download as PDF
7124
Federal Register / Vol. 81, No. 27 / Wednesday, February 10, 2016 / Notices
Contact Person for More Information:
Jaya Raman, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
docket number NIOSH–260–A, by any
of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
FOR FURTHER INFORMATION CONTACT:
Charles Geraci, NIOSH, Education and
Information Division, Nanotechnology
Research Center, 1090 Tusculum
Avenue, Cincinnati, Ohio 45226,
telephone (513) 533–8339 (not a toll free
number).
Dated: February 3, 2016.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2016–02582 Filed 2–9–16; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2016–02647 Filed 2–9–16; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket Number CDC–2016–0001; NIOSH–
260–A]
Centers for Medicare & Medicaid
Services
Draft Current Intelligence Bulletin:
Health Effects of Occupational
Exposure to Silver Nanomaterials;
Notice of Public Meeting; Availability
of Document for Comment; Extension
of Comment Period
[Document Identifier: CMS–276, CMS–1957,
CMS–10599 and CMS–10600]
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice and extension of
comment period.
AGENCY:
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
asabaliauskas on DSK9F6TC42PROD with NOTICES2
VerDate Sep<11>2014
17:22 Feb 09, 2016
Jkt 238001
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
SUMMARY:
On January 21, 2016, the
Director of the National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
published a notice in the Federal
Register [81 FR 3425] announcing the
availability of the following draft
document for public comment entitled
Draft Current Intelligence Bulletin:
Health Effects of Occupational Exposure
to Silver Nanomaterials. Written
comments were to be received by March
21, 2016. NIOSH is extending the public
comment period until April 22, 2016.
DATES: NIOSH is extending the
comment period on the document
published January 21, 2016 (81 FR
3425). Electronic or written comments
must be received by April 22, 2016.
ADDRESSES: You may submit comments,
identified by CDC–2016–0001 and
SUMMARY:
Agency Information Collection
Activities: Proposed Collection;
Comment Request
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
minimize the information collection
burden.
Comments must be received by
April 11, 2016:
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number __, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
DATES:
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–276 Prepaid Health Plan Cost
Report
CMS–1957 Social Security Office (SSO)
Report of State Buy-in Problem
CMS–10599 Medicare Prior
Authorization of Home Health
Services Demonstration
CMS–10600 Evaluation of the Medicare
Patient Intravenous Immunoglobulin
Demonstration
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
E:\FR\FM\10FEN1.SGM
10FEN1
asabaliauskas on DSK9F6TC42PROD with NOTICES2
Federal Register / Vol. 81, No. 27 / Wednesday, February 10, 2016 / Notices
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Prepaid Health
Plan Cost Report; Use: Health
Maintenance Organizations and
Competitive Medical Plans (HMO/
CMPs) contracting with the Secretary
under Section 1876 of the Social
Security Act are required to submit a
budget and enrollment forecast, semiannual interim report, 4th Quarter
interim report, and a final certified cost
report in accordance with 42 CFR
417.572–417.576. Health Care
Prepayment Plans (HCPPs) contracting
with the Secretary under Section 1833
of the Social Security Act are required
to submit a budget and enrollment
forecast, semi-annual interim report,
and final cost report in accordance with
42 CFR 417.808 and 42 CFR 417.810.
Form Number: CMS–276 (OMB control
number 0938–0165); Frequency:
Quarterly; Affected Public: Private
Sector (Business or other for-profits);
Number of Respondents: 91; Total
Annual Responses: 74; Total Annual
Hours: 3728. (For policy questions
regarding this collection contact Bilal
Farrakh at 410–786–4456.)
2. Type of Information Collection
Request: Reinstatement of a previously
approved collection; Title of
Information Collection: Social Security
Office (SSO) Report of State Buy-in
Problem; Use: Under Section 1843 of the
Social Security Act, States may enter
into an agreement with the Department
of Health and Human Services to enroll
eligible individuals in Medicare and pay
their premiums. The purpose of the
State Buy-in’ program is to assure that
Medicaid is the payer of last resort by
permitting a State to provide Medicare
protection to certain groups of needy
individuals, as part of the State’s total
assistance plan. State Buy-in also has
the effect of transferring some medical
costs for this population from the
VerDate Sep<11>2014
17:22 Feb 09, 2016
Jkt 238001
Medicaid program, which is partially
State funded to the Medicare program,
which is funded by the federal
government and individual premiums.
Generally, the States Buy-in for
individuals who meet the eligibility
requirements for Medicare and are cash
recipients or deemed cash recipients or
categorically needy under Medicaid. In
some cases, States may also include
individuals who are not cash assistance
recipients under the Medical Assistance
Only group. The day-to-day operations
of the State Buy-in program is
accomplished through an automated
data exchange process. The automated
data exchange process is used to
exchange Medicare and Buy-in
entitlement information between the
Social Security District Offices,
Medicaid State Agencies and the
Centers for Medicare & Medicaid
Services. When problems arise however
that cannot be resolved though the
normal data exchange process, clerical
actions are required. The CMS–1957,
‘‘SSO Report of State Buy-In Problem’’
is used to report Buy-in problems cases.
The CMS–1957 is the only standardized
form available for communications
between the aforementioned agencies
for the resolution of beneficiary
complaints and inquiries regarding State
Buy-in eligibility. Form Number: CMS–
1957 (OMB control number: 0938–
0035); Frequency: Reporting—Annually;
Affected Public: Individuals and
Households; Number of Respondents:
3,936; Total Annual Responses: 3,936;
Total Annual Hours: 1,311. (For policy
questions regarding this collection
contact Keith Robinson at 410–786–
1148.)
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare Prior
Authorization of Home Health Services
Demonstration; Use: Section 402(a)(1)(J)
of the Social Security Amendments of
1967 (42 U.S.C. 1395b–1(a)(1)(J))
authorizes the Secretary to ‘‘develop or
demonstrate improved methods for the
investigation and prosecution of fraud
in the provision of care or services
under the health programs established
by the Social Security Act (the Act).’’ In
accordance with this authority, we seek
to develop and implement a Medicare
demonstration project, which we
believe will help assist in developing
improved procedures for the
identification, investigation, and
prosecution of Medicare fraud occurring
among HHAs providing services to
Medicare beneficiaries.
This demonstration would help
assure that payments for home health
services are appropriate before the
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
7125
claims are paid, thereby preventing
fraud, waste, and abuse. As part of this
demonstration, we propose performing
prior authorization before processing
claims for home health services in:
Florida, Texas, Illinois, Michigan, and
Massachusetts. We would establish a
prior authorization procedure that is
similar to the Prior Authorization of
Power Mobility Device (PMD)
Demonstration, which was implemented
by CMS in 2012. This demonstration
would also follow and adopt prior
authorization processes that currently
exist in other health care programs such
as TRICARE, certain state Medicaid
programs, and in private insurance.
The information required under this
collection is requested by Medicare
contractors to determine proper
payment or if there is a suspicion of
fraud. Medicare contractors will request
the information from HHA providers
submitting claims for payment from the
Medicare program in advance to
determine appropriate payment. Form
Number: CMS–10599 (OMB control
number: 0938–NEW); Frequency:
Occasionally; Affected Public: Private
sector (Business or other for-profits and
Not-for-profits); Number of
Respondents: 908,740; Number of
Responses: 908,740; Total Annual
Hours: 454,370. (For questions regarding
this collection contact Carla David
(410)786–4799.)
4. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Evaluation of
the Medicare Patient Intravenous
Immunoglobulin Demonstration; Use:
Primary Immune Deficiency Diseases
(PIDD) are caused by genetic defects that
result in a lack of and/or impaired
antibody function. Without antibodies,
the body’s immune system is not able to
function effectively. Immunoglobulin
(IG) therapy is used to temporarily
replace some of the antibodies
(immunoglobulins) that are missing or
not working properly in people with
PIDD.
By special statutory provision,
Medicare Part B covers intravenous
immunoglobulin (IVIG) for persons with
PIDD who wish to receive the drug inhome, but does not allow for Medicare
to cover any of the items and services
needed to administer the drug unless
the person is homebound or otherwise
receiving services under a Medicare
home health episode of care. Therefore,
most beneficiaries with PIDD receive
treatment at hospital outpatient
departments, physicians’ offices, and
other outpatient settings. A current
alternative to IVIG is subcutaneous
immunoglobulin (SCIG), a product that
E:\FR\FM\10FEN1.SGM
10FEN1
asabaliauskas on DSK9F6TC42PROD with NOTICES2
7126
Federal Register / Vol. 81, No. 27 / Wednesday, February 10, 2016 / Notices
permits some beneficiaries to selfadminister the immunoglobulin (IG)
safely at home without an attending
healthcare professional. SCIG at home is
reimbursed by Medicare. However,
there are limitations to SCIG—e.g., the
need for more frequent administration
and higher volumes of solution, which
can reach a maximum absorbable level
for some patients that is below their
optimum IG treatment level—that
inhibit more widespread use of SCIG.
Under the Medicare Patient IVIG
Access Demonstration project, by
paying for the items and services
needed to administer the IVIG drug inhome, Medicare will enable
beneficiaries and their physicians to
have greater flexibility in choosing the
option that is most appropriate for the
beneficiary. With the exception of
coverage of these items and services, no
other aspects of Medicare coverage for
IVIG (e.g., drugs approved for coverage
or PIDD diagnoses covered) will change
under the demonstration.
The Medicare Patient IVIG Access
Demonstration project mandates CMS
to:
• Evaluate the impact of the Medicare
IVIG Access Demonstration project on
Medicare beneficiary access to IVIG at
home,
• Determine the appropriateness of
implementing a new payment
methodology for IVIG in all settings and
determining an appropriate payment
amount, and
• Update the existing 2007 Office of
the Assistant Secretary for Planning and
Evaluation (ASPE) report Analysis of
Supply, Distribution, Demand, and
Access Issues Associated with Immune
Globulin Intravenous (IGIV) (2007 ASPE
Report).
The impact evaluation seeks to
understand the experiences of
demonstration participants and nonparticipants, to update the 2007 ASPE
report, and to support the payment
methodology through the use of
qualitative and quantitative data
collection. The qualitative data
collection will consist of a series of
stakeholder interviews. Interviews with
IVIG/SCIG physicians and nurses will
provide information on the experiences
of beneficiaries from the perspective of
those who have significant, in-depth
and practical hands-on experience with
delivering IG to Medicare beneficiaries
with and without access to home
infusions. We will be able to gather their
knowledge of beneficiaries’ experiences
with the care, as well as information on
any potential health consequences due
to changes in IG medication or
participation in the Demonstration.
Lastly, we will gather the physicians
VerDate Sep<11>2014
17:22 Feb 09, 2016
Jkt 238001
and nurses’ views of the degree to
which beneficiaries believe the program
is effective, including the cost
effectiveness for beneficiaries who use
the services provided under the
Demonstration. Form Number: CMS–
10600 (OMB control number: 0938–
NEW); Frequency: Annually; Affected
Public: Individuals and Households;
State, Local or Tribal Governments;
Private Sector (Business or other forprofit); Number of Respondents: 2,488;
Total Annual Responses: 2,488; Total
Annual Hours: 483. (For policy
questions regarding this collection
contact Pauline Karikari-Martin at 410–
786–1040).
Dated: February 5, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2016–02686 Filed 2–9–16; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–1728–94]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ACTION:
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
SUMMARY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Comments on the collection(s) of
information must be received by the
OMB desk officer by March 11, 2016.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Home Health
Agency Cost Report; Use: Providers of
Services participating in the Medicare
program are required under sections
1815(a), 1833(e) and1861(v)(1)(A) of the
Social Security Act (42 U.S.C. 1395g) to
submit annual information to achieve
DATES:
E:\FR\FM\10FEN1.SGM
10FEN1
Agencies
[Federal Register Volume 81, Number 27 (Wednesday, February 10, 2016)]
[Notices]
[Pages 7124-7126]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02686]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-276, CMS-1957, CMS-10599 and CMS-10600]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
DATES: Comments must be received by April 11, 2016:
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' Web site address at https://www.cms.hhs.gov/PaperworkReductionActof1995.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: Reports Clearance Office at (410) 786-
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-276 Prepaid Health Plan Cost Report
CMS-1957 Social Security Office (SSO) Report of State Buy-in Problem
CMS-10599 Medicare Prior Authorization of Home Health Services
Demonstration
CMS-10600 Evaluation of the Medicare Patient Intravenous Immunoglobulin
Demonstration
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management
[[Page 7125]]
and Budget (OMB) for each collection of information they conduct or
sponsor. The term ``collection of information'' is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and includes agency requests or
requirements that members of the public submit reports, keep records,
or provide information to a third party. Section 3506(c)(2)(A) of the
PRA requires federal agencies to publish a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice.
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Prepaid Health
Plan Cost Report; Use: Health Maintenance Organizations and Competitive
Medical Plans (HMO/CMPs) contracting with the Secretary under Section
1876 of the Social Security Act are required to submit a budget and
enrollment forecast, semi-annual interim report, 4th Quarter interim
report, and a final certified cost report in accordance with 42 CFR
417.572-417.576. Health Care Prepayment Plans (HCPPs) contracting with
the Secretary under Section 1833 of the Social Security Act are
required to submit a budget and enrollment forecast, semi-annual
interim report, and final cost report in accordance with 42 CFR 417.808
and 42 CFR 417.810. Form Number: CMS-276 (OMB control number 0938-
0165); Frequency: Quarterly; Affected Public: Private Sector (Business
or other for-profits); Number of Respondents: 91; Total Annual
Responses: 74; Total Annual Hours: 3728. (For policy questions
regarding this collection contact Bilal Farrakh at 410-786-4456.)
2. Type of Information Collection Request: Reinstatement of a
previously approved collection; Title of Information Collection: Social
Security Office (SSO) Report of State Buy-in Problem; Use: Under
Section 1843 of the Social Security Act, States may enter into an
agreement with the Department of Health and Human Services to enroll
eligible individuals in Medicare and pay their premiums. The purpose of
the State Buy-in' program is to assure that Medicaid is the payer of
last resort by permitting a State to provide Medicare protection to
certain groups of needy individuals, as part of the State's total
assistance plan. State Buy-in also has the effect of transferring some
medical costs for this population from the Medicaid program, which is
partially State funded to the Medicare program, which is funded by the
federal government and individual premiums. Generally, the States Buy-
in for individuals who meet the eligibility requirements for Medicare
and are cash recipients or deemed cash recipients or categorically
needy under Medicaid. In some cases, States may also include
individuals who are not cash assistance recipients under the Medical
Assistance Only group. The day-to-day operations of the State Buy-in
program is accomplished through an automated data exchange process. The
automated data exchange process is used to exchange Medicare and Buy-in
entitlement information between the Social Security District Offices,
Medicaid State Agencies and the Centers for Medicare & Medicaid
Services. When problems arise however that cannot be resolved though
the normal data exchange process, clerical actions are required. The
CMS-1957, ``SSO Report of State Buy-In Problem'' is used to report Buy-
in problems cases. The CMS-1957 is the only standardized form available
for communications between the aforementioned agencies for the
resolution of beneficiary complaints and inquiries regarding State Buy-
in eligibility. Form Number: CMS-1957 (OMB control number: 0938-0035);
Frequency: Reporting--Annually; Affected Public: Individuals and
Households; Number of Respondents: 3,936; Total Annual Responses:
3,936; Total Annual Hours: 1,311. (For policy questions regarding this
collection contact Keith Robinson at 410-786-1148.)
3. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Medicare Prior
Authorization of Home Health Services Demonstration; Use: Section
402(a)(1)(J) of the Social Security Amendments of 1967 (42 U.S.C.
1395b-1(a)(1)(J)) authorizes the Secretary to ``develop or demonstrate
improved methods for the investigation and prosecution of fraud in the
provision of care or services under the health programs established by
the Social Security Act (the Act).'' In accordance with this authority,
we seek to develop and implement a Medicare demonstration project,
which we believe will help assist in developing improved procedures for
the identification, investigation, and prosecution of Medicare fraud
occurring among HHAs providing services to Medicare beneficiaries.
This demonstration would help assure that payments for home health
services are appropriate before the claims are paid, thereby preventing
fraud, waste, and abuse. As part of this demonstration, we propose
performing prior authorization before processing claims for home health
services in: Florida, Texas, Illinois, Michigan, and Massachusetts. We
would establish a prior authorization procedure that is similar to the
Prior Authorization of Power Mobility Device (PMD) Demonstration, which
was implemented by CMS in 2012. This demonstration would also follow
and adopt prior authorization processes that currently exist in other
health care programs such as TRICARE, certain state Medicaid programs,
and in private insurance.
The information required under this collection is requested by
Medicare contractors to determine proper payment or if there is a
suspicion of fraud. Medicare contractors will request the information
from HHA providers submitting claims for payment from the Medicare
program in advance to determine appropriate payment. Form Number: CMS-
10599 (OMB control number: 0938-NEW); Frequency: Occasionally; Affected
Public: Private sector (Business or other for-profits and Not-for-
profits); Number of Respondents: 908,740; Number of Responses: 908,740;
Total Annual Hours: 454,370. (For questions regarding this collection
contact Carla David (410)786-4799.)
4. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection:
Evaluation of the Medicare Patient Intravenous Immunoglobulin
Demonstration; Use: Primary Immune Deficiency Diseases (PIDD) are
caused by genetic defects that result in a lack of and/or impaired
antibody function. Without antibodies, the body's immune system is not
able to function effectively. Immunoglobulin (IG) therapy is used to
temporarily replace some of the antibodies (immunoglobulins) that are
missing or not working properly in people with PIDD.
By special statutory provision, Medicare Part B covers intravenous
immunoglobulin (IVIG) for persons with PIDD who wish to receive the
drug in-home, but does not allow for Medicare to cover any of the items
and services needed to administer the drug unless the person is
homebound or otherwise receiving services under a Medicare home health
episode of care. Therefore, most beneficiaries with PIDD receive
treatment at hospital outpatient departments, physicians' offices, and
other outpatient settings. A current alternative to IVIG is
subcutaneous immunoglobulin (SCIG), a product that
[[Page 7126]]
permits some beneficiaries to self-administer the immunoglobulin (IG)
safely at home without an attending healthcare professional. SCIG at
home is reimbursed by Medicare. However, there are limitations to
SCIG--e.g., the need for more frequent administration and higher
volumes of solution, which can reach a maximum absorbable level for
some patients that is below their optimum IG treatment level--that
inhibit more widespread use of SCIG.
Under the Medicare Patient IVIG Access Demonstration project, by
paying for the items and services needed to administer the IVIG drug
in-home, Medicare will enable beneficiaries and their physicians to
have greater flexibility in choosing the option that is most
appropriate for the beneficiary. With the exception of coverage of
these items and services, no other aspects of Medicare coverage for
IVIG (e.g., drugs approved for coverage or PIDD diagnoses covered) will
change under the demonstration.
The Medicare Patient IVIG Access Demonstration project mandates CMS
to:
Evaluate the impact of the Medicare IVIG Access
Demonstration project on Medicare beneficiary access to IVIG at home,
Determine the appropriateness of implementing a new
payment methodology for IVIG in all settings and determining an
appropriate payment amount, and
Update the existing 2007 Office of the Assistant Secretary
for Planning and Evaluation (ASPE) report Analysis of Supply,
Distribution, Demand, and Access Issues Associated with Immune Globulin
Intravenous (IGIV) (2007 ASPE Report).
The impact evaluation seeks to understand the experiences of
demonstration participants and non-participants, to update the 2007
ASPE report, and to support the payment methodology through the use of
qualitative and quantitative data collection. The qualitative data
collection will consist of a series of stakeholder interviews.
Interviews with IVIG/SCIG physicians and nurses will provide
information on the experiences of beneficiaries from the perspective of
those who have significant, in-depth and practical hands-on experience
with delivering IG to Medicare beneficiaries with and without access to
home infusions. We will be able to gather their knowledge of
beneficiaries' experiences with the care, as well as information on any
potential health consequences due to changes in IG medication or
participation in the Demonstration. Lastly, we will gather the
physicians and nurses' views of the degree to which beneficiaries
believe the program is effective, including the cost effectiveness for
beneficiaries who use the services provided under the Demonstration.
Form Number: CMS-10600 (OMB control number: 0938-NEW); Frequency:
Annually; Affected Public: Individuals and Households; State, Local or
Tribal Governments; Private Sector (Business or other for-profit);
Number of Respondents: 2,488; Total Annual Responses: 2,488; Total
Annual Hours: 483. (For policy questions regarding this collection
contact Pauline Karikari-Martin at 410-786-1040).
Dated: February 5, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2016-02686 Filed 2-9-16; 8:45 am]
BILLING CODE 4120-01-P